Celsion Corp. (Nasdaq; CLSN) is buying Egen Inc. for $14 million in cash and stock.

Egen, headquartered in Huntsville, Alabama, focuses on developing drugs to treat cancer and other diseases.

Subscribe Now

Complete access to real-time information and analysis of news and trends in the industry.

14-Day Free Trial

No credit card required. Complete access to articles, breaking news and industry data.